Showing 1 - 7 results of 7 for search 'Alexei F. Kisselev', query time: 0.03s Refine Results
  1. 1
    Site-Specific Proteasome Inhibitors

    Site-Specific Proteasome Inhibitors by Alexei F. Kisselev

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

    Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2 by Ibtisam Ibtisam, Alexei F Kisselev

    Published 2024-04-01
    Get full text
    Article
  3. 3
    A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax

    A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax by Sondra L. Downey-Kopyscinski, Sriraja Srinivasa, Alexei F. Kisselev

    Published 2022-07-01
    Get full text
    Article
  4. 4
    DNA-Histone Cross-Links: Formation and Repair

    DNA-Histone Cross-Links: Formation and Repair by Manideep C. Pachva, Alexei F. Kisselev, Bakhyt T. Matkarimov, Murat Saparbaev, Regina Groisman

    Published 2020-12-01
    Get full text
    Article
  5. 5
    NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells

    NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells by Umit Aliyaskarova, Yeldar Baiken, Flore Renaud, Sophie Couve, Alexei F. Kisselev, Murat Saparbaev, Regina Groisman

    Published 2023-03-01
    Get full text
    Article
  6. 6
    Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib.

    Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib. by Tamer B Shabaneh, Sondra L Downey, Ayrton L Goddard, Michael Screen, Marcella M Lucas, Alan Eastman, Alexei F Kisselev

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein

    Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein by Tyler W. Jenkins, Sondra L. Downey-Kopyscinski, Jennifer L. Fields, Gilbert J. Rahme, William C. Colley, Mark A. Israel, Andrey V. Maksimenko, Steven N. Fiering, Alexei F. Kisselev

    Published 2021-05-01
    Get full text
    Article

Search Tools: